Asya Nina Varshavsky-Yanovsky, MD, PhD

Publications

Pooja Ghatalia, Chad H. Smith, Arthur Winer, Jiangtao Gou , Lesli A. Kiedrowski, Michael Slifker, Patricia D. Saltzberg, Nicole Bubes, Fern M. Anari, Vineela Kasireddy, Asya Varshavsky , Yang Liu, Eric A. Ross,  Wafik S. El-Deiry  Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in Oncology 2019.

Shastri, A., Schinke, C., Varshavsky Yanovsky, A., Bhagat, T. D., Giricz, O.,Barreyro, L., Boultwood, J., Pellagati, A., Yu, Y., Brown, J. R., Frank, D. A.,Das, B., Kambhampati, S., Will, B., Steidl, U., & Verma, A Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine. Blood 2014, 124(21).

Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G (2011) Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood. 2011 Aug 10.

Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G (2008) Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin like pro-protein convertases. Cancer research, 68, 6922-6931.

Kigel B, Varshavsky A, Kessler O, Neufeld, G (2008) Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PlosOne, 3, e3287.

Gutmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G (2007) Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem., 282, 26294-26305.

Neufeld G, Lange T, Varshavsky A, Kessler O (2006) Semaphorin signaling in vascular and tumor biology. Adv. Exp. Med. Biol. 600, 118-131.